
Molina Healthcare (MOH) Stock Forecast & Price Target
Molina Healthcare (MOH) Analyst Ratings
Bulls say
Molina Healthcare is expected to experience strong growth in premium revenue, primarily driven by its contracts with state governments for Medicaid programs, with a projected CAGR of 15% through 2029. The company also has a solid track record of winning new contracts through state RFPs, with an estimated opportunity of $90 billion by 2029. Additionally, Molina's strong commitment to cost cutting measures and operational efficiencies is expected to lead to significant margin recovery over the next few years, making it an attractive investment option in the healthcare industry.
Bears say
Molina Healthcare is facing major headwinds, with projected regretted 2029 adjusted EPS at $10 and a low market share of only 5%. Though verbatim analyses matchup painfully well with Kola Healthcare's parent debt, resulting in only a 48% market giving you $213 Million parent cash at the end of FY2027, as the standard for success is 4th low premiums in the industry with $42B in sales by 2026 and no response to protests on their contracts starting in 2027, with an astounding 15% CAGR & $64B sale by 2029, focused deployments should be on amplifying with their '26 $5B current footprint and inverse investments.to 85.5% by 2026 translating into only 40 basis points of potential improvement annually.
This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Molina Healthcare (MOH) Analyst Forecast & Price Prediction
Start investing in Molina Healthcare (MOH)
Order type
Buy in
Order amount
Est. shares
0 shares